Innovaciones en el diagnóstico molecular

Inicio
Noticias
Innovaciones en el diagnóstico molecular: técnicas y tecnologías

Innovaciones en el diagnóstico molecular: técnicas y tecnologías

Comunicate con el proveedor:

Contactar

!noticia guardada!

1. Valero VP. The Clinical Laboratory in the health care system. SEMERGEN - Med Fam. marzo de 2011;37(3):111-2.

2. J. Farfán BM. Molecular biology in clinical diagnosis. Rev Médica Clínica Las Condes. noviembre de 2015;26(6):788-93.

3. Molecular Diagnostics Market Size, Share, Industry Report, 2023 [Internet]. [citado 30 de agosto de 2016]. Disponible en: https://www.gminsights.com/industry-analysis/molecular-diagnostics-market

4. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:263-73.

5. Kiechle FL, Holland CA. Point-of-Care Testing and Molecular Diagnostics: Miniaturization Required. Clin Lab Med. septiembre de 2009;29(3):555-60.

6. Poritz MA, Blaschke AJ, Byington CL, Meyers L, Nilsson K, Jones DE, et al. FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract Infection. PLOS ONE. 19 de octubre de 2011;6(10):e26047.

7. Buss SN, Leber A, Chapin K, Fey PD, Bankowski MJ, Jones MK, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol. marzo de 2015;53(3):915-25.

8. Leber AL, Everhart K, Balada-Llasat J-M, Cullison J, Daly J, Holt S, et al. Multicenter Evaluation of the BioFire FilmArray Meningitis Encephalitis Panel for the Detection of Bacteria, Viruses and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol. 22 de junio de 2016;JCM.00730-16.

9. Peñata A, Salazar R, Castaño T, Bustamante J, Ospina S. Diagnóstico molecular de tuberculosis extrapulmonar y sensibilidad a rifampicina con un método automatizado en tiempo real. Biomédica. diciembre de 2016;36:78-89.

10. García-Gutierrez V, Casares MTG, Antonio JV, Manuel AJ, Osorio S, Hernández-Boluda JC, et al. Molecular Response at 3 Months Measured with Genexpert BCR-ABL (IS) Platform Predicts Further Outcome in Chronic Myeloid Patients but the Cutoff Differs from the 10% Commonly Used with BCR-ABL (IS) EUTOS Method. Blood. 3 de diciembre de 2015;126(23):2776-2776.

11. Kostić T, Ellis M, Williams MR, Stedtfeld TM, Kaneene JB, Stedtfeld RD, et al. Thirty-minute screening of antibiotic resistance genes in bacterial isolates with minimal sample preparation in static self-dispensing 64 and 384 assay cards. Appl Microbiol Biotechnol. 2015;99(18):7711-22.

12. Giebel R, Worden C, Rust SM, Kleinheinz GT, Robbins M, Sandrin TR. Microbial fingerprinting using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) applications and challenges. Adv Appl Microbiol. 2010;71:149-84.

13. Buermans HPJ, den Dunnen JT. Next generation sequencing technology: Advances and applications. Biochim Biophys Acta BBA - Mol Basis Dis. octubre de 2014;1842(10):1932-41.

14. Reza R, Teresa M. DNA sequencing: historical and technical considerations. Rev Colomb Biotecnol. julio de 2014;16(1):5-8.

15. Switt M, I A, Toledo V. Infectious diseases in the genomic era. Rev Chil Infectol. octubre de 2015;32(5):571-6.

16. Lohmann K, Klein C. Next generation sequencing and the future of genetic diagnosis. Neurother J Am Soc Exp Neurother. octubre de 2014;11(4):699-707.

17. Roma-Rodrigues C, Fernandes AR. Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy. Appl Clin Genet. 3 de octubre de 2014;7:195-208.

18. Jiang T, Tan M-S, Tan L, Yu J-T. Application of next-generation sequencing technologies in Neurology. Ann Transl Med [Internet]. diciembre de 2014 [citado 7 de septiembre de 2016];2(12). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260045/